## CHRW: C.H. Robinson Worldwide, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 2.6% below STRENGTH zone (3.0-6.0%); PEG 2.25 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($151.40)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Is C.H. Robinson Stock Outperforming the Dow?**
- Source: Markets Financial Content | 20251216T070736 | Bullish | Relevance: 100%
- C.H. Robinson Worldwide, Inc. (CHRW) stock has significantly outperformed the Dow Jones Industrial Average, with gains of 18.3% in three months, 41.5% in 52 weeks, and 52.6% year-to-date. This strong performance is supported by robust Q3 2025 adjusted EPS growth and an increased 2026 operating income target. Wall Street analysts maintain a "Moderate Buy" rating for CHRW, indicating continued confidence in its trajectory.

**2. Is C.H. Robinson Stock Outperforming the Dow?**
- Source: Barchart.com | 20251216T073037 | Bullish | Relevance: 100%
- C.H. Robinson Worldwide, Inc. (CHRW) stock has significantly outperformed the Dow Jones Industrial Average ($DOWI) over the past three months, 52 weeks, and year-to-date, signaling strong investor confidence despite revenue declines. The company reaffirmed its profitability narrative by raising its 2026 operating income target and trading above analyst price targets, with a "Moderate Buy" rating. This performance also outpaces its rival, Expeditors International of Washington, Inc. (EXPD).

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Stifel | $184 | $155 | +19% |
| 2025-12-16 | Barclays | $200 | $145 | +38% |
| 2025-12-08 | Morgan Stanley | $85 | $77 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Stifel | main | Buy |
| 2025-12-16 | Barclays | up | Overweight |
| 2025-12-08 | Morgan Stanley | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($1.86M) |
| Sells | 2 ($0.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.0% (-3.0%)
- First Eagle Investme: 8.9% (-0.2%)
- Blackrock Inc.: 8.2% (-8.5%)
- Wellington Managemen: 6.1% (+198.6%)
- State Street Corpora: 5.8% (-7.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +22%) could attract flows.
- Momentum building: MRS_10 improving +2.8% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.25 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 34%). Analyst sentiment positive (3 raises, avg +22%). Insider buying signal ($1.9M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $18.8B |
| Beta | 0.91 |
| 52W Range | $84.68 - $162.79 |
| Short Interest | 7.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.25 |
| Forward P/E | 26.5 |
| Current P/E | 31.9 |
| YoY Growth | 20.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.2% to 2.6% (+2.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.4pp (needs >3.0% for momentum thesis). MRS_5 at 1.3% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-0.61), momentum weakening. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.58% (CS: 73) | Neutral |
| RSI_14 | 60.4 | Neutral |
| MACD Histogram | -0.61 | Bearish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.092x | Above |
| vs SMA200 | 1.375x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $159.04
- **Stop Loss:** $151.40 (4.8% risk)
- **Target:** $166.68 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 157
- **Position Value:** $24,969.28
- **Portfolio %:** 24.97%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-01-28 (Est: $1.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.40 | +7.4% |
| 2025Q2 | $1.16 | $1.29 | +11.6% |
| 2025Q1 | $1.05 | $1.17 | +11.4% |
| 2024Q4 | $1.11 | $1.21 | +9.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*